ISIN | LU1645386217 |
---|---|
Valorennummer | 37504775 |
Bloomberg Global ID | SHEMC SW |
Fondsname | UBS (Lux) Fund Solutions - J.P. Morgan USD EM Diversified Bond 1-5 UCITS ETF (hedged to CHF) A-acc |
Fondsanbieter |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fondsanbieter | UBS Asset Management Switzerland AG, Zurich |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) |
UBS AG Basel Telefon: +41 61 288 20 20 UBS AG, Zürich Zürich Telefon: +41 44 234 11 11 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Bond Emerging Global |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Transaktionsgebühr zugunsten des Fonds (Beitrag zur Deckung der Spesen bei der Anlage neu zufliessender Mittel) |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund aims to track, before expenses, the price and income performance of the J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index (Total Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below. |
Besonderheiten |
Aktueller Preis * | 10.26 CHF | 15.04.2025 |
---|---|---|
Vorheriger Preis * | 10.25 CHF | 14.04.2025 |
52 Wochen Hoch * | 10.42 CHF | 03.03.2025 |
52 Wochen Tief * | 9.94 CHF | 16.04.2024 |
NAV * | 10.26 CHF | 15.04.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 351'017'544 | |
Anteilsklassevermögen *** | 5'596'005 | |
Trading Information SIX |
YTD-Performance | +0.24% |
31.12.2024 - 15.04.2025
31.12.2024 15.04.2025 |
---|---|---|
1 Monat | -1.26% |
17.03.2025 - 15.04.2025
17.03.2025 15.04.2025 |
3 Monate | -0.10% |
15.01.2025 - 15.04.2025
15.01.2025 15.04.2025 |
6 Monate | -0.30% |
15.10.2024 - 15.04.2025
15.10.2024 15.04.2025 |
1 Jahr | +2.88% |
15.04.2024 - 15.04.2025
15.04.2024 15.04.2025 |
2 Jahre | +6.65% |
17.04.2023 - 15.04.2025
17.04.2023 15.04.2025 |
3 Jahre | +2.00% |
19.04.2022 - 15.04.2025
19.04.2022 15.04.2025 |
5 Jahre | +2.76% |
15.04.2020 - 15.04.2025
15.04.2020 15.04.2025 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Kuwait (State Of) | 1.04% | |
---|---|---|
Poland (Republic of) | 0.81% | |
Oman (Sultanate Of) | 0.76% | |
Ghana (Republic of) | 0.73% | |
Teva Pharmaceutical Finance Netherlands III B.V. | 0.72% | |
PETRONAS Capital Ltd. | 0.71% | |
Romania (Republic Of) | 0.71% | |
Philippines (Republic Of) | 0.65% | |
Standard Chartered PLC | 0.65% | |
Dominican Republic | 0.64% | |
Letzte Daten-Aktualisierung | 10.04.2025 |
TER | 0.38% |
---|---|
Datum TER | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.38% |
Ongoing Charges *** | 0.38% |
SRRI ***
|
|
Datum SRRI *** | 31.03.2025 |